July 18, 2018
TapImmune Inc., Jacksonville's publicly traded developer of cancer-fighting immunotherapies, announced in May that it was merging with Minnesota-based Marker Therapeutics Inc., another developer of immunotherapies.
Read More
July 5, 2018
Company developing immunotherapy treatments for cancer up 139 percent this year.
Read More
